Dow Down 0.62% Nasdaq Up 0.35%

More On TRL.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Acerus Pharmaceuticals Corporation (TRL.TO)

-Toronto
0.43 Down 0.02(4.44%) Sep 10
Prev Close:0.45
Open:0.45
Bid:0.43
Ask:0.44
1y Target Est:N/A
Beta:-2.21992
Next Earnings Date:N/A
Day's Range:0.43 - 0.45
52wk Range:0.31 - 0.86
Volume:32,500
Avg Vol (3m):146,316
Market Cap:86.38M
P/E (ttm):N/A
EPS (ttm):-0.04
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):7.97
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.01
Quarterly EPS Est (Dec-15) :-0.01
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, develops, distributes, and sells medications for male hypogonadism, female sexual dysfunction, and respiratory disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback